Literature DB >> 8803514

What happens to long-term medication when general practice patients are referred to hospital?

W Himmel1, M Tabache, M M Kochen.   

Abstract

OBJECTIVE: The aim of the study was to determine changes in drug treatment of general practitioners' patients on hospital admission and after discharge, and to identify communication problems.
METHODS: During 15 months all chronically ill patients of one general practice who were referred to hospital (n = 130) were followed-up prospectively with regard to long-term medication in general practice, drugs recommended in hospital for continuing treatment and medication after discharge from hospital.
RESULTS: Before hospital admission the 130 patients were receiving 420 medicines long-term (14% generic drugs). The hospital doctors cancelled 28% (116/420) of the drugs, 6% were replaced by other drugs, 11% by another brand name (identical chemical substance but different producer) and 31 generics were replaced by brand name drugs. Hospitals exhibited specific drug profiles (e.g., total replacement of some generics by brand name drugs; and exclusive administration of a certain preparation regardless of the general practitioner's prescription). After discharge from hospital, the general practitioner continued 329 of the 496 drugs (66.1%) recommended by hospital, 105 (21%) drugs were replaced by other drugs (49 of them by generics) and 62 drugs (13%) were cancelled. The general practitioner received detailed information about drug change in only five of the 130 hospital discharge letters.
CONCLUSION: 50% turnover in drug use between general practice and hospital and some of the patterns of drug change in hospital may be unnecessary. They may also complicate the difficult task of the general practitioner of maintaining a patient's drug regimen.

Entities:  

Mesh:

Year:  1996        PMID: 8803514     DOI: 10.1007/s002280050103

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  36 in total

1.  Impact of medication reconciliation at discharge on continuity of patient care in France.

Authors:  Mélanie Van Hollebeke; Sarah Talavera-Pons; Aurélien Mulliez; Valérie Sautou; Gilles Bommelaer; Armand Abergel; Anne Boyer
Journal:  Int J Clin Pharm       Date:  2016-07-18

2.  Rule-based standardised switching of drugs at the interface between primary and tertiary care.

Authors:  Stefanie U Walk; Thilo Bertsche; Jens Kaltschmidt; Markus G Pruszydlo; Torsten Hoppe-Tichy; Ingeborg Walter-Sack I; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2007-11-25       Impact factor: 2.953

3.  Medication report reduces number of medication errors when elderly patients are discharged from hospital.

Authors:  Patrik Midlöv; Lydia Holmdahl; Tommy Eriksson; Anna Bergkvist; Bengt Ljungberg; Håkan Widner; Christina Nerbrand; Peter Höglund
Journal:  Pharm World Sci       Date:  2007-07-28

4.  The Iowa Continuity of Care study: Background and methods.

Authors:  Barry L Carter; Karen B Farris; Paul W Abramowitz; David B Weetman; Peter J Kaboli; Jeffrey D Dawson; Paul A James; Alan J Christensen; John M Brooks
Journal:  Am J Health Syst Pharm       Date:  2008-09-01       Impact factor: 2.637

5.  Recognition and management of potential drug-drug interactions in patients on internal medicine wards.

Authors:  Priska Vonbach; André Dubied; Jürg H Beer; Stephan Krähenbühl
Journal:  Eur J Clin Pharmacol       Date:  2007-09-06       Impact factor: 2.953

6.  Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study.

Authors:  Nariman Mansur; Avraham Weiss; Amnon Hoffman; Tsipora Gruenewald; Yichayaou Beloosesky
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Reasons for drug changes implemented by secondary care.

Authors:  W Himmel; M M Kocken
Journal:  Br J Gen Pract       Date:  1997-12       Impact factor: 5.386

8.  Congruence on medication between patients and physicians involved in patient course.

Authors:  S Foss; J R Schmidt; T Andersen; J J Rasmussen; J Damsgaard; K Schaefer; L K Munck
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

9.  Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany.

Authors:  Sebastian Harder; Philipp Fischer; Markus Krause-Schäfer; Klaus Ostermann; Gottfried Helms; Helge Prinz; Mike Hahmann; Horst Baas
Journal:  Eur J Clin Pharmacol       Date:  2004-12-01       Impact factor: 2.953

10.  Substantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm.

Authors:  Renate Quinzler; Simon P W Schmitt; Maria Pritsch; Jens Kaltschmidt; Walter E Haefeli
Journal:  BMC Med Inform Decis Mak       Date:  2009-06-12       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.